In brief
http://www.100md.com
《英国医生杂志》
Cloning attempt fails: Panos Zavos, the fertility doctor who said last month that he had transferred a cloned human embryo into the womb of a 35 year old woman (24 January, p 185), announced last week that his client had failed to become pregnant.
GMC to consult on revalidation: The General Medical Council has launched a consultation exercise on quality assurance in revalidation, aimed at gathering ideas on the current proposals. The council wants to ensure that the evidence that doctors will be asked to provide will be valid and reliable and capable of being verified. The paper is available on the GMC's website (www.gmcuk.org).
Infectious disease expert resigns after conviction: Dr Thomas Campbell Butler, the expert on plague who was recently convicted on charges relating to the disappearance of plague bacteria from his laboratory at Texas Tech University ( BMJ 2003:327: 1307), has resigned as a professor and has agreed to reimburse the university for contracts with drug companies. Dr Butler will be sentenced in early March.
Danish court rules against Roche: A Danish court has ruled that Roche, the manufacturer of the antimalarial drug mefloquine (Lariam), failed to issue patient information leaflets with the drug in Denmark, despite instructions from the government that it must do so. A traveller who experienced severe mental disturbances after taking two tablets successfully argued that neither he nor his doctor were aware of the side effects. The court ordered Roche to pay Kr10 700 (￡980; $1820; 1440) in compensation.
MRC announces ￡5m for brain sciences research: The Medical Research Council this week announced the award of 29 grants worth ￡5m ($9.3m; 7.3m) as part of its initiative to strengthen UK brain sciences research. More information can be accessed at www.mrc.ac.uk/funding-bscall-successful.htm
GMC to consult on revalidation: The General Medical Council has launched a consultation exercise on quality assurance in revalidation, aimed at gathering ideas on the current proposals. The council wants to ensure that the evidence that doctors will be asked to provide will be valid and reliable and capable of being verified. The paper is available on the GMC's website (www.gmcuk.org).
Infectious disease expert resigns after conviction: Dr Thomas Campbell Butler, the expert on plague who was recently convicted on charges relating to the disappearance of plague bacteria from his laboratory at Texas Tech University ( BMJ 2003:327: 1307), has resigned as a professor and has agreed to reimburse the university for contracts with drug companies. Dr Butler will be sentenced in early March.
Danish court rules against Roche: A Danish court has ruled that Roche, the manufacturer of the antimalarial drug mefloquine (Lariam), failed to issue patient information leaflets with the drug in Denmark, despite instructions from the government that it must do so. A traveller who experienced severe mental disturbances after taking two tablets successfully argued that neither he nor his doctor were aware of the side effects. The court ordered Roche to pay Kr10 700 (￡980; $1820; 1440) in compensation.
MRC announces ￡5m for brain sciences research: The Medical Research Council this week announced the award of 29 grants worth ￡5m ($9.3m; 7.3m) as part of its initiative to strengthen UK brain sciences research. More information can be accessed at www.mrc.ac.uk/funding-bscall-successful.htm